After Senate confirmation vote, says “Dr. Califf is now in place to lead an agency that regulates over $4 trillion annually and affects the lives of nearly every single American”
WASHINGTON, February 24 – Senate health committee Chairman Lamar Alexander (R-Tenn.) today made the following statement after the Senate approved Dr. Robert Califf to lead the Food and Drug Administration (FDA):
“Dr. Califf is now in place to lead an agency that regulates over $4 trillion annually and affects the lives of nearly every single American. A major priority of the Senate health committee this year is our biomedical innovation agenda – companion legislation to the House’s 21st Century Cures Act – to help get safe and effective drugs and medical devices into doctors’ offices and medicine cabinets more quickly. Dr. Califf will be a good partner in that effort, helping us get a result for American patients.”
The Senate health committee has been working on its biomedical innovation agenda since last year and earlier this month passed seven bills with bipartisan support. It will consider more proposals with bipartisan support in March and in April. Alexander said of this effort: “The House has completed its work on the 21st Century Cures Act. The president has announced his support for a precision medicine initiative and a cancer ‘moonshot.’ It is urgent that the Senate finish its work and turn into law these ideas that will help virtually every American.”
The Senate health committee held a hearing on November 17, 2015, to consider Dr. Califf’s nomination. The Senate health committee approved Dr. Califf’s nomination on January 12, 2016.
For access to this release and Chairman Alexander’s other statements, click here.
Margaret Atkinson / Jim Jeffries: 202-224-0387